| CMF-01220 | IRAK3 | down-regulates | LMO2 | activates | R-206 | 4 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-03090 | LAMA3 | down-regulates | LMO2 | activates | R-203 | 4 | 1 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |
| CMF-04955 | ABCC5 | down-regulates | LMO2 | activates | R-206 | 4 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-06977 | ATRX | down-regulates | LMO2 | activates | R-206 | 4 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-11845 | SKIV2L | up-regulates | LMO2 | activates | R-203 | 4 | 1 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |
| CMF-13824 | ADAMTS8 | down-regulates | LMO2 | activates | R-203 | 4 | 3 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |
| CMF-14381 | NR3C2 | up-regulates | LMO2 | activates | R-206 | 4 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-15883 | ADNP2 | up-regulates | LMO2 | activates | R-206 | 4 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-16885 | CR2 | down-regulates | LMO2 | activates | R-206 | 4 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-18090 | DLGAP2 | up-regulates | LMO2 | activates | R-206 | 4 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-21905 | PRAME | up-regulates | LMO2 | activates | R-203 | 4 | 1 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |
| CMF-22673 | IDH1 | down-regulates | LMO2 | activates | R-206 | 4 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-23859 | TP53 | down-regulates | LMO2 | activates | R-203 | 4 | 3 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |
| CMF-23860 | TP53 | down-regulates | LMO2 | activates | R-206 | 4 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-27009 | OR4N3P | up-regulates | LMO2 | activates | R-206 | 4 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-27268 | PUM1 | up-regulates | LMO2 | activates | R-203 | 4 | 1 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |
| CMF-28498 | OR10H1 | up-regulates | LMO2 | activates | R-206 | 4 | 2 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-29214 | AQP10 | down-regulates | LMO2 | activates | R-203 | 4 | 1 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |
| CMF-32117 | A6B1_AND_A6B4_INTEGRIN_SIGNALING | up-regulates | LMO2 | activates | R-203 | 4 | 3 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |
| CMF-32118 | A6B1_AND_A6B4_INTEGRIN_SIGNALING | up-regulates | LMO2 | activates | R-206 | 4 | 3 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
| CMF-33688 | BCR_SIGNALING_PATHWAY | up-regulates | LMO2 | activates | R-203 | 4 | 2 | Drugs (49) Regulator Drugs (0)Regulon Drugs (49)FOSTAMATINIB DISODIUM, INFLIXIMAB, MIDOSTAURIN, ATN-161, CSL-324, ONERCEPT, R-343, BIIB-023, DASATINIB, R-348, AMY-101, LIPEGFILGRASTIM, PEGSUNERCEPT, GOLIMUMAB, CERDULATINIB, FILGRASTIM, HMPL-523, ETANERCEPT, BALUGRASTIM, AFELIMOMAB, SOTRASTAURIN, OZORALIZUMAB, ILORASERTIB, CERTOLIZUMAB PEGOL, RO-5458640, UCN-01, PF-04605412, NEIHULIZUMAB, XL-228, ENTOSPLETINIB, R-333, GUSACITINIB, REMTOLUMAB, TG100-801, PEGCETACOPLAN, LENOGRASTIM, MIVAVOTINIB CITRATE, ADALIMUMAB, VOLOCIXIMAB, FOSTAMATINIB, PLACULUMAB, DELCASERTIB, LANRAPLENIB, MIVAVOTINIB, PEGFILGRASTIM, VESENCUMAB, GSK-690693, AL-78898A, ENMD-981693 |